Stuart L. Schreiber

Stuart L. Schreiber is a Professor of Chemistry and Chemical Biology at Harvard University, affiliated with the Department of Chemistry and Chemical Biology. His research focuses on bioorganic chemical biology and organic chemistry, with an emphasis on discovering small molecules that modulate therapeutic targets. His work includes studies on signaling pathways, gene regulation, and mechanisms of cancer resistance. Schreiber's lab also explores brain health maintenance and therapeutic agents. He is an Emeritus Morris Loeb Professor and a Howard Hughes Medical Institute Investigator. His research group contributes to diversity-oriented synthesis and discovery-based screening. Schreiber is involved in multiple advisory roles and serves on the Board of Directors of several biotechnology companies.